Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Piramal Pharma Limited ( (IN:PPLPHARMA) ) has provided an announcement.
Piramal Pharma Limited announced the approval of a resolution to appoint Ms. Nathalie Leitch as a Non-Executive, Non-Independent Director following a postal ballot and remote e-voting process. The resolution was passed with the requisite majority, reflecting shareholder support and potentially strengthening the company’s governance structure.
More about Piramal Pharma Limited
Piramal Pharma Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company provides a range of services and products, including critical care, consumer products, and contract development and manufacturing services, catering to a global market.
YTD Price Performance: -15.36%
Average Trading Volume: 382,791
Current Market Cap: 282.1B INR
For a thorough assessment of PPLPHARMA stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue